The statistical risk of diagnosing coincidental acquired hemophilia A following anti‐SARS‐CoV‐2 vaccination
Authors:
- 21 December 2022
- journal article
- letter
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 19 (9) , 2360-2362
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 VaccinationNew England Journal of Medicine, 2021
- A case report of acquired hemophilia following COVID‐19 vaccineJournal of Thrombosis and Haemostasis, 2021
- De novo acquired hemophilia as an immune dysregulation phenomenon following SARS‐CoV‐2 infectionTransfusion, 2020
- The rising incidence of acquired haemophilia A in GermanyHaemophilia, 2020
- Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)Journal of Thrombosis and Haemostasis, 2012
- A case of acquired haemophilia following H1N1 vaccinationHaemophilia, 2011
- Acquired factor VIII haemophilia following influenza vaccinationEuropean Journal of Clinical Pharmacology, 2010
- Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' OrganisationBlood, 2006
- Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapyArchives of internal medicine (1960), 1987
- Acquired HemophiliaArchives of internal medicine (1960), 1987